12 Best Healthcare stocks to Buy and Hold for 5 Years

Page 2 of 10

9. IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Number of Hedge Fund Holders: 48

IDEXX Laboratories, Inc. (NASDAQ:IDXX) specializes in animal health diagnostics, veterinary software, and laboratory services, supporting companion animals, livestock, water testing, and food safety worldwide. Its platforms, including imaging systems, in-clinic analyzers, and point-of-care tools, enable veterinarians to quickly diagnose and treat a wide range of conditions.

In August 2025, IDXX reported impressive Q2 earnings, with revenue of $1.11 billion, a 10.6% year-over-year increase, and earnings per share rising to $3.63, far exceeding market expectations. These results prompted the business to raise its full-year revenue and profit forecasts, reflecting continued momentum in diagnostics and laboratory services.

A key growth driver has been the rollout of the inVue Dx analyzer, a rapid blood and ear canal diagnostic device. Roughly 2,400 units were installed in Q2, prompting an upward revision of the full-year installation target to 5,500 units. This launch strengthens IDXX’s leadership in point-of-care veterinary testing and supports accelerating organic growth.

Analysts now project 2025 earnings per share between $12.40 and $12.76, reflecting expanding margins and strong operational performance. Over the past three years, IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares have returned 97%, significantly outperforming competitors such as Zoetis and the broader market, highlighting its position as a top-performing stock in the animal health sector.

Page 2 of 10